Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Oct 20, 2007 1:41pm
417 Views
Post# 13609263

recent move

recent moveI am very encouraged by this bounce-back, and the fact that we have clearly eaten up alot of the big overhang of stock that's been smothering us for a month or so. I am not entirely clear what the catalyst is here, although it would seem that most of this was spurred by Paradigm's quite reputable summary of the 1402 opportunity, and how imminent things might be, how much the risk / reward has improved, and how huge the potential really is if things go well.... As we have been saying for 6 months or so, I am not so focussed on the revenue NOW... although I would admittedly like to see a continued increase in recurring revenue this quarter... I am still primarilly focussed on the one indisputably good licensing deal or agreement, that will take cash burn issue out of the equation. I think we have to face the reality that even though the underlying revenue stream is growing well with great clients...its still likely to be lumpy. ONE SOLID DEAL... with associated guaranteed cash... will take the dilution issue off the table.. and get the quick trade / hedge fund shorters out of our hair. Lets face it, its the repeated disappointments and overoptimism, that led us to repeated dilution and financings, that have made us a very easy target for manipulators... and they have played us like a fiddle two or three times now. The good news in all of that, is the fact that the speculative premium on this stock has been completely wiped out, to the extent that in my opinion the market cap of this stock doesnt even come close to representing the true underlying value, especially with the clarity of recent developments unfolding. The reality is, even though 1402 is front and center, we have two or three other really solid and newsworthy catalysts that can all have a big impact on this whole story... With any of these things coming to frution, I think the market will start to value the rest of the company reasonably... and we'll get the oft mentioned credibility we need so badly... and then the updside on this thing is beyond our current imagination. Finally some fun.. patience is rewarded... I am not selling a thing
Bullboard Posts